Ci Investments Inc. Catalent, Inc. Transaction History

Ci Investments Inc.

$26.5 Billion
Q4 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$56.16 - $60.96 $19,319 - $20,970	-344 Reduced 7.47%	4,261 $258,000
Q2 2024 Aug 12, 2024	SELL	$53.58 - $57.02 $21,110 - $22,465	-394 Reduced 7.88%	4,605 $259,000
Q1 2024 May 13, 2024	BUY	$42.56 - $59.82 $94,696 - $133,099	2,225 Added 80.21%	4,999 $282,000
Q4 2023 Feb 12, 2024	SELL	$32.18 - $46.57 $73,531 - $106,412	-2,285 Reduced 45.17%	2,774 $125,000
Q3 2023 Nov 13, 2023	SELL	$44.2 - $50.2 $24,310 - $27,610	-550 Reduced 9.81%	5,059 $230,000
Q2 2023 Aug 11, 2023	BUY	$31.86 - $67.26 $87,328 - $184,359	2,741 Added 95.57%	5,609 $243,000
Q1 2023 May 12, 2023	BUY	$45.44 - $74.26 $34,852 - $56,957	767 Added 36.51%	2,868 $188,000
Q4 2022 Feb 10, 2023	BUY	$41.39 - $81.0 $67,589 - $132,273	1,633 Added 348.93%	2,101 $95,000
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $14,327 - $22,393	198 Added 73.33%	468 $34,000
Q2 2022 Aug 12, 2022	SELL	$87.2 - $114.05 $50,576 - $66,149	-580 Reduced 68.24%	270 $29,000
Q1 2022 May 12, 2022	SELL	$94.19 - $124.49 $7,158 - $9,461	-76 Reduced 8.21%	850 $94,000
Q4 2021 Feb 11, 2022	BUY	$119.57 - $139.07 $20,805 - $24,198	174 Added 23.14%	926 $119,000
Q3 2021 Nov 12, 2021	BUY	$109.17 - $142.35 $82,095 - $107,047	752 New	752 $100,000
Q2 2021 Aug 13, 2021	SELL	$100.34 - $115.69 $743,419 - $857,147	-7,409 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$101.51 - $125.27 $170,232 - $210,077	1,677 Added 29.26%	7,409 $780,000
Q4 2020 Feb 09, 2021	BUY	$85.88 - $105.36 $183,096 - $224,627	2,132 Added 59.22%	5,732 $597,000
Q3 2020 Nov 09, 2020	SELL	$72.74 - $92.5 $1,673 - $2,127	-23 Reduced 0.63%	3,600 $308,000
Q2 2020 Aug 07, 2020	BUY	$48.02 - $79.04 $173,976 - $286,361	3,623 New	3,623 $266,000

Others Institutions Holding CTLT

# of Institutions

118

Shares Held

37.8M

Call Options Held

123K

Put Options Held

432K

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.

Account